Background Increasing attention is focused on the relationship of inflammation biomarkers
with malignant tumors. The purpose of the present study was to detect whether the …

Inflammatory proteins activate platelets, which have been observed to be directly related to
cancer progression and development. The aim of this systematic review is to investigate the …

Background/Aim: The platelet-to-lymphocyte ratio (PLR) is a promising prognostic marker in
some malignancies. The present study evaluated the clinical impact of the PLR in patients …

The aim of this study is to search the most powerful prognostic factor from routine blood test
for esophageal squamous cell cancer (ESCC) patients. Multiple laboratory tests were …

Introduction There are few known predictors of gastric cancer (GC). In this study, we
evaluated the relationship between peripheral blood parameters and disease in patients …

An increased mean platelet volume (MPV) is recognized as an early marker of platelet
activation. The diagnostic and prognostic impact of the MPV and MPV/platelet count (PC) …

The present study was aim to investigate the prognostic role of platelet to lymphocyte ratio
(PLR) for patients with gastric cancer (GC) using meta-analysis. A total of 13 studies (14 …

Purpose Patients with type 2 diabetes mellitus (T2DM) have an increased risk of breast
cancer (BC). Furthermore, growing evidence suggests that activated platelets play a crucial …

We have read with great interest the article ''Mean platelet volume (MPV) could be possible
biomarker in early diagnosis and monitoring of gastric cancer (GC)''by Kılınçalp et al.[1]. This …

Background Pre-treatment PLR (platelet-lymphocyte ratio) was reported to be associated
with the prognosis in gastric cancer (GC), but the results remain inconclusive. This meta …